However, the reduced expression of PD-L1 and less infiltration of MDSCs and cytokines/chemokines in luteolin treatment encouraged researchers to explore the anti-HCC effect of luteolin [59,60]. The gene discussed is CD274; the disease is hepatocellular carcinoma.